Baldwin Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Baldwin Investment Management's EW Position: Q1 2026 in Review
Baldwin Investment Management reduced its Edwards Lifesciences (EW) stake by 5.1% in Q1 2026, selling an estimated $63.9K and leaving 14,320 shares worth $1.15M. The position accounts for 0.13% of the portfolio, ranked #90.
Baldwin Investment Management first reported a position in EW in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.29M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Baldwin Investment Management held 14,320 shares of Edwards Lifesciences worth $1.15M as of Q1 2026.
- Baldwin Investment Management sold 775 Edwards Lifesciences shares in Q1 2026, an estimated $63.9K.
- Edwards Lifesciences made up 0.13% of Baldwin Investment Management's portfolio in Q1 2026, its #90 holding.
- Baldwin Investment Management first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 20 quarters since.
- Baldwin Investment Management's Edwards Lifesciences position peaked at $1.29M in Q4 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Baldwin Investment Management's 13F filing for Q1 2026, filed 12 May 2026.